Tracking abnormal cervical cancer screening: Evaluation of an EMR-based intervention

Journal of General Internal Medicine

Volumn 25, Issue 6, 2010, Pages 575-580

  Dupuis, Elizabeth A ^a   White, Hilary F ^a   Newman, Daniel ^a   Sobieraj, Jerome E ^a   Gokhale, Manjusha ^b   Freund, Karen M ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cervical cancer; Pap smear; Papillomavirus

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; CANCER SCREENING; CLINICAL EVALUATION; CLINICAL PRACTICE; ELECTRONIC MEDICAL RECORD; EUROPEAN AMERICAN; FEMALE; FOLLOW UP; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HEALTH CENTER; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; UTERINE CERVIX CANCER;

ADOLESCENT; ADULT; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CONTINUITY OF PATIENT CARE; DELIVERY OF HEALTH CARE; EARLY DETECTION OF CANCER; ELECTRONIC HEALTH RECORDS; FEMALE; HUMANS; REMINDER SYSTEMS; URBAN POPULATION; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 77955089438     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-010-1287-z     Document Type: Article

References (16)

1. The American Cancer Society. What Are the Key Statistics About Cervical Cancer? http://www.cancer.org/docroot/CRI/content/CRI-2-4-1X-What-are-the-key- statistics-for-cervical-cancer-8.asp. Accessed January 28, 2010.
2. Schiffman MH, Brinton LA, Devesa SS. Cervical cancer. In: Schottenfeld D, Fraumeni JF, eds. Cancer Epidemiology and Prevention. 2nd ed. New York: Oxford University Press; 1996:1090-1116
3. Peterson NB, Han J, Freund KM. Inadequate follow-up for abnormal Pap smears in an urban population. J Natl Med Assoc. 2003;95(9):825-832
4. Leyden WA, Manos MM, Geiger AM, et al. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst. 2005;97(9):675-683
5. Marcus AC, Crane LA, Kaplan CP, et al. Improving adherence to screening follow-up among women with abnormal Pap smears: results from a large clinic-based trial of three intervention strategies. Med Care. 1992;30(3):216-230
6. Cartwight PS, Reed G. No-show behavior in a county hospital clinic. Am J Gynecol Health. 1990;6:15-21.
7. Laedtke TW, Dignan M. Compliance with therapy for cervical dysplasia among women of low socioeconomic status. South Med J.1992;85(1):5-8.
8. Lane DS. Compliance with referrals from a cancer-screening project. J Fam Pract. 1983;17(5):811-817
9. Carey P, Gjerdingen DK. Follow-up of abnormal Papanicolaou smears among women of different races. J Fam Pract. 1993;37(6):583-587
10. Nathoo V. Investigation of non-responders at a cervical cancer screening clinic in Manchester. Br Med J (Clin Res Ed). 1988;296(6628):1041-1042
11. Paskett ED, White E, Carter WB, Chu J. Improving follow-up after an abnormal Pap smear: a randomized controlled trial. Prev Med. 1990;19 (6):630-641
12. Freund KM, Battaglia TA, Calhoun E, et al. National Cancer Institute Patient Navigation Research Program: methods, protocol, and measures. Cancer. 2008;113(12):3391-3399
13. Townsend RW. Formation and operation of a captive insurance company for malpractice coverage. Coll Rev. 1988;5:47-61.
14. National Committee for Quality Assurance (NCQA). Standards and Guidelines for Physician Practice Connections-Patient-Centered Medical Home (PPC-PCMH): 2008.
15. Norris SL, Nichols PJ, Caspersen CJ, et al. The effectiveness of disease and case management for people with diabetes. A systematic review. Am J Prev Med. 2002;22(4 Suppl):15-38.
16. Battaglia TA, Roloff K, Posner MA, Freund KM. Improving follow-up to abnormal breast cancer screening in an urban population. A patient navigation intervention. Cancer. 2007;109(2 Suppl):359-367